Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
59°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
88.49
+0.48 (+0.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biontech Se ADR
< Previous
1
2
3
4
5
6
7
8
9
...
52
53
Next >
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
Today 15:00 EDT
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Assessing BioNTech: Insights From 11 Financial Analysts
April 17, 2024
Via
Benzinga
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
April 12, 2024
Via
Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
April 09, 2024
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around.
Via
InvestorPlace
CureVac, GS Partner Release Data On Influenza Vaccine Study
April 04, 2024
CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen coverage with acceptable safety. Positive findings against influenza A...
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For BioNTech
March 21, 2024
Via
Benzinga
Earnings Outlook For BioNTech
March 19, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For BioNTech
February 20, 2024
Via
Benzinga
The 3 Best Bargain Stocks to Buy in Q2 2024
March 31, 2024
For those who don’t want to chase what everyone else is acquiring, these are intriguing ideas for best bargain stocks to buy.
Via
InvestorPlace
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
March 26, 2024
These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.
Via
InvestorPlace
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript
March 20, 2024
BNTX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...
Via
Benzinga
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
March 20, 2024
BioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc (NYSE: PFE) for saving the world from the pandemic with their jointly developed vaccine.
Via
Benzinga
Exposures
COVID-19
Stocks Quietly Higher As Central Bank Wraps Up Meeting
March 20, 2024
Stocks are cautiously higher ahead of the conclusion of the central bank's policy meeting.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q4 2023
March 20, 2024
BNTX stock results show that BioNTech missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts
March 20, 2024
BioNTech also reported plummeting earnings that missed forecasts and issued light 2024 guidance.
Via
Investor's Business Daily
Why Is BioNTech Stock Trading Lower On Wednesday?
March 20, 2024
BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5-€3.1 billion,...
Via
Benzinga
US Stock Futures Stall As Traders Await Fed Chair Powell's Decision; Analyst Sees S&P 500 Showing 'Signs Of Near-Term Top'
March 20, 2024
Investors remain cautious ahead of the Federal Reserve‘s interest rate decision, with stock futures on Wednesday hinting at a lower opening.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Earnings Scheduled For March 20, 2024
March 20, 2024
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.
Via
Benzinga
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
March 13, 2024
One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.
Via
InvestorPlace
The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
March 06, 2024
Explore the ups and downs of 3 meme stocks: Imperial Petroleum, Novavax and MicroCloud, as they navigate market challenges and speculation.
Via
InvestorPlace
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
March 06, 2024
With excellent financial health and great prospects, these three biotech stocks just may be the the next stars of the sector.
Via
InvestorPlace
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
March 04, 2024
While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities.
Via
InvestorPlace
It’s Time! 3 Dodgy Pharma Stocks to Sell in February
March 04, 2024
Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action.
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
March 04, 2024
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 12, 2024
Via
Benzinga
3 Blue-Chip Stocks to Buy at a 52-Week Low in February
February 07, 2024
Higher-for-longer interest rates and undervalued metrics make it a good time to look for blue-chip stocks at a low price.
Via
InvestorPlace
Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets
February 03, 2024
Inmagene Biopharma of Shanghai transferred 7.5% of its shares to HutchMed for global rights to two clinical stage immunology assets. It will also be responsible for up to $230 million in milestones.
Via
Talk Markets
3 Pharma Stocks to Sell in February Before They Crash and Burn
February 02, 2024
The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.
Via
InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
3
4
5
6
7
8
9
...
52
53
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.